Literature DB >> 33528711

A prediction model of simple echocardiographic variables to screen for potentially correctable shunts in adult patients with pulmonary arterial hypertension associated with atrial septal defects: a cross-sectional study.

Mingqi Li1,2, Yu Wang1,2, Hezhi Li1, Yigao Huang1, Tao Huang1, Caojin Zhang3, Hongwen Fei4.   

Abstract

During the routine follow-up of adult patients with pulmonary arterial hypertension associated with atrial septal defects (ASD-PAH), the suitability of shunt closure depends on the invasive right heart catheterization (RHC). It is difficult to grasp the timing of RHC shunt closure for moderate-severe PAH. This retrospective cross-sectional study was designed to investigate which echocardiographic variables are related to pulmonary vascular resistance (PVR) in adult ASD-PAH patients and propose a method using echocardiographic variables to screen for patients where shunt closure is suitable. A total of 139 adult ASD-PAH patients with a PASP ≥ 60 mmHg measured by transthoracic echocardiogram (TTE) were included in this study. All RHCs were performed within a week after TTE. The Correctable shunt was defined as PVR ≤ 4.6 wood units (WU). Multivariate regressions were performed with echocardiographic variables. The nomogram of prediction model was constructed by the predictors of PVR ≤ 4.6 WU by multivariate logistic regression analysis. Multivariate linear regression revealed that TAPSE (tricuspid annular plane systolic excursion)/pulmonary artery systolic pressure (PASP) measured by TTE was negatively associated with PVR (β per SD: - 1.84, 95%CI - 2.62, - 1.06). Multivariate logistic regression showed that TAPSE/PASP and pulmonary valve (PV) peak velocity were positively associated with a potentially correctable shunt (PVR ≤ 4.6 WU) (OR per SD: 2.38, 95%CI 1.34, 4.25, and OR per SD: 2.67, 95%CI 1.26, 5.64, respectively). In receiver operating characteristic analysis, the TAPSE/PASP + PV peak velocity combined model achieved the best performance (AUC: 0.8584, sensitivity: 83.33%, specificity: 72.16%). Internal verification showed stable performance (AUC: 0.8591, sensitivity: 88.10%, specificity: 68.04%). The net benefit of this model was greater than other models when it came to a wide range probability threshold in decision curve analysis. TAPSE/PASP + PV the peak velocity model may have great value in predicting adult ASD-PAH patients with operability potential, which could help clinicians make the treatment decision for follow-up patients.

Entities:  

Keywords:  Atrial septal defect; Echocardiography; Pulmonary arterial hypertension; Pulmonary vascular resistance

Year:  2021        PMID: 33528711     DOI: 10.1007/s10554-020-02128-5

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  21 in total

1.  Tricuspid annular plane systolic excursion and pulmonary arterial systolic pressure relationship in heart failure: an index of right ventricular contractile function and prognosis.

Authors:  M Guazzi; F Bandera; G Pelissero; S Castelvecchio; L Menicanti; S Ghio; P L Temporelli; R Arena
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-30       Impact factor: 4.733

2.  Area under the free-response ROC curve (FROC) and a related summary index.

Authors:  Andriy I Bandos; Howard E Rockette; Tao Song; David Gur
Journal:  Biometrics       Date:  2008-05-13       Impact factor: 2.571

Review 3.  The Eisenmenger syndrome in adults.

Authors:  W Vongpatanasin; M E Brickner; L D Hillis; R A Lange
Journal:  Ann Intern Med       Date:  1998-05-01       Impact factor: 25.391

4.  2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Karen K Stout; Curt J Daniels; Jamil A Aboulhosn; Biykem Bozkurt; Craig S Broberg; Jack M Colman; Stephen R Crumb; Joseph A Dearani; Stephanie Fuller; Michelle Gurvitz; Paul Khairy; Michael J Landzberg; Arwa Saidi; Anne Marie Valente; George F Van Hare
Journal:  Circulation       Date:  2019-04-02       Impact factor: 29.690

5.  Accuracy of Doppler-derived estimation of pulmonary vascular resistance in congenital heart disease: an index of operability.

Authors:  Gholam Hossein Ajami; Sirous Cheriki; Hamid Amoozgar; Mohammad Borzouee; Manoucher Soltani
Journal:  Pediatr Cardiol       Date:  2011-07-22       Impact factor: 1.655

6.  Pulmonary arterial hypertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease.

Authors:  Peter M Engelfriet; Marielle G J Duffels; Thomas Möller; Eric Boersma; Jan G P Tijssen; Erik Thaulow; Michael A Gatzoulis; Barbara J M Mulder
Journal:  Heart       Date:  2006-12-12       Impact factor: 5.994

7.  2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT).

Authors:  Nazzareno Galiè; Marc Humbert; Jean-Luc Vachiery; Simon Gibbs; Irene Lang; Adam Torbicki; Gérald Simonneau; Andrew Peacock; Anton Vonk Noordegraaf; Maurice Beghetti; Ardeschir Ghofrani; Miguel Angel Gomez Sanchez; Georg Hansmann; Walter Klepetko; Patrizio Lancellotti; Marco Matucci; Theresa McDonagh; Luc A Pierard; Pedro T Trindade; Maurizio Zompatori; Marius Hoeper
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

8.  A simple method for noninvasive estimation of pulmonary vascular resistance.

Authors:  Amr E Abbas; F David Fortuin; Nelson B Schiller; Christopher P Appleton; Carlos A Moreno; Steven J Lester
Journal:  J Am Coll Cardiol       Date:  2003-03-19       Impact factor: 24.094

Review 9.  Atrial septal defect with pulmonary hypertension: when/how can we consider closure?

Authors:  Shreepal Jain; Bharat Dalvi
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

10.  Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease.

Authors:  R Condliffe; P Clift; K Dimopoulos; R M R Tulloh
Journal:  Pulm Circ       Date:  2018-07-23       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.